The Mismatch Between Infection-Related Deaths and Research Efforts 🔬

What We're Showing

The percentage of global deaths related to bacterial infections compared to the percentage of clinical trials related to bacterial infections. Data is from The Center for Global Development and The Lancet.

Key Takeaways

• Almost 14% of global deaths are caused by bacterial infections, yet less than 2% of all clinical trials study bacterial infections.
• With rising antibiotic resistance, new drugs are desperately needed—but research isn’t keeping up.
• Investors can help fund research to help accelerate the development of new drugs or alternative treatments.